TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BIOPHARMASPEC

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BIOPHARMASPEC

ST13

US500000079154693

Classe

41, 42

Pedido

79154693

Registro

4801698

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

39

Atualização mais recente

05/06/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

41, 42

Data de depósito

22/04/2014

Data de registro

01/09/2015

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

05/06/2025

Última transação

05/06/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

JERSEY, GB

Examinador

LEE, YATSYE ISADORA

Localização atual

Historical data usage

Titulares e representantes

Titulares

Biopharmaspec Limited
Biopharmaspec Limited

Representantes

Hara K. Jacobs Ballard Spahr LLP

Classificação técnica

Classes Nice

Classe 41Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 41

Educational, training and instructional services in the nature of courses, seminars, tutorials, conferences and workshops in the field of scientific research and analysis; providing education and training services, namely, training courses, seminars, tutorials, conferences and workshops on scientific analysis and analytical techniques; production of sound and video recordings in the field of scientific research and analysis for training purposes; publication of training manuals and educational, instructional and teaching materials; publication of scientific reports and texts; providing online electronic publications, namely, electronic books and journals in the field of scientific research and analysis; information, advisory and consultancy services relating to all of the aforesaid services

Classe 42

Scientific research and development services; scientific analytical services, namely, chemical and biochemical analysis services for scientific research purposes; scientific analysis of materials and substances; development of scientific analytical methods; pharmaceutical, biopharmaceutical and biotechnological discovery, research and development services; pharmacokinetics research and development services; pre-clinical analytical testing services; laboratory services for analytical testing; bacteria testing and analysis services; sample testing and analysis services; mass spectrometry services; chromatography services; protein and glycoprotein analysis and sequencing; carbohydrate analysis and sequencing; gas phase sequencing; gel electrophoresis analysis; SEC MALLS analysis Size Exclusion Chromatography (SEC) with Multi-Angle Laser-Light Scattering-protein aggregation analysis; amino acid and sugar composition analysis; protein aggregation analysis; scientific research involving structural characterization of biopolymers, small molecule drugs and metabolites; compilation and provision of scientific data in the field of chemistry and biochemistry for research purposes; scientific data interpretation services, namely, scientific analysis in the field of chemistry and biochemistry; preparation and provision of scientific reports, namely, providing scientific information in the fields of chemistry and biochemistry; provision of certificates of analysis, namely, for the purpose of certifying the results of scientific analysis; design of computer software or computer programs for scientific or analytical applications; providing temporary use of on-line, non-downloadable software for automated presentation and interpretation of scientific data; information, advisory and consultancy services relating to all of the aforesaid services

Publicações

Histórico de despachos e eventos da marca no USPTO.

39 publicações encontradas

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

05/06/2025

71AG

REGISTERED-SEC.71 ACCEPTED

05/06/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/06/2025

ES71

TEAS SECTION 71 RECEIVED

11/02/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

01/09/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

23/02/2024

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

07/02/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/02/2022

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

07/02/2022

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

07/02/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/02/2022

ES75

TEAS SECTION 71 & 15 RECEIVED

20/07/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/09/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/08/2018

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

13/02/2016

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/01/2016

FIMP

FINAL DISPOSITION PROCESSED

27/01/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/12/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

01/09/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

16/06/2015

PUBO

PUBLISHED FOR OPPOSITION

16/06/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

27/05/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/05/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/05/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/04/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/04/2015

ALIE

ASSIGNED TO LIE

14/04/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/04/2015

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/04/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/04/2015

RFNT

REFUSAL PROCESSED BY IB

12/12/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

24/11/2014

RFRR

REFUSAL PROCESSED BY MPU

24/11/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/11/2014

CNRT

NON-FINAL ACTION WRITTEN

20/11/2014

MAFR

APPLICATION FILING RECEIPT MAILED

18/11/2014

DOCK

ASSIGNED TO EXAMINER

14/11/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

14/11/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

13/11/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BIOPHARMASPEC ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.